113 related articles for article (PubMed ID: 1740633)
1. Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effects.
Saivin S; Petitou M; Lormeau JC; Dupouy D; Sie P; Caranobe C; Houin G; Boneu B
J Lab Clin Med; 1992 Feb; 119(2):189-96. PubMed ID: 1740633
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effects.
Saivin S; Petitou M; Lormeau JC; Dupouy D; Sié P; Caranobe C; Houin G; Boneu B
Thromb Haemost; 1992 Mar; 67(3):346-51. PubMed ID: 1322569
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbit.
Saivin S; Caranobe C; Petitou M; Lormeau JC; Houin G; Boneu B
Thromb Haemost; 1992 May; 67(5):550-5. PubMed ID: 1325682
[TBL] [Abstract][Full Text] [Related]
4. Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbit.
Briant L; Caranobe C; Saivin S; Sié P; Bayrou B; Houin G; Boneu B
Thromb Haemost; 1989 Jun; 61(3):348-53. PubMed ID: 2552603
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
Amar J; Caranobe C; Sie P; Boneu B
Br J Haematol; 1990 Sep; 76(1):94-100. PubMed ID: 2223652
[TBL] [Abstract][Full Text] [Related]
6. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of CY 216 and of its ACLM and BCLM components in the rabbit.
Peyrou V; Lormeau JC; Caranobe C; Gabaig AM; Crepon B; Saivin S; Houin G; Sié P; Boneu B
Thromb Haemost; 1994 Aug; 72(2):268-74. PubMed ID: 7831664
[TBL] [Abstract][Full Text] [Related]
8. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
Kaiser B; Hauptmann J; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
[TBL] [Abstract][Full Text] [Related]
9. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
Bendayan P; Boccalon H; Dupouy D; Boneu B
Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
[TBL] [Abstract][Full Text] [Related]
10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216.
Carrie D; Caranobe C; Saivin S; Houin G; Petitou M; Lormeau JC; Van Boeckel C; Meuleman D; Boneu B
Blood; 1994 Oct; 84(8):2571-7. PubMed ID: 7919374
[TBL] [Abstract][Full Text] [Related]
12. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
Peyrou V; Béguin S; Boneu B; Hemker HC
Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
[TBL] [Abstract][Full Text] [Related]
13. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
Ofosu FA; Smith LM; Anvari N; Blajchman MA
Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
[TBL] [Abstract][Full Text] [Related]
14. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit.
Carrie D; Caranobe C; Boneu B
Br J Haematol; 1993 Apr; 83(4):622-6. PubMed ID: 8390849
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.
Bendetowicz AV; Béguin S; Caplain H; Hemker HC
Thromb Haemost; 1994 Mar; 71(3):305-13. PubMed ID: 8029794
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic and anticoagulant properties of synthetic polyanions: sulfated bis-aldonic acid amides.
Klauser RJ; Raake W; Meinetsberger E; Zeiller P
J Pharmacol Exp Ther; 1991 Oct; 259(1):8-14. PubMed ID: 1656031
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
